Skip to main content
ORTIN GLOBAL LIMITED logo

ORTIN GLOBAL LIMITED — Investor Relations & Filings

Ticker · ORTINGLOBE ISIN · INE749B01020 BSE.NS Manufacturing
Open in API
Filings indexed 203 across all filing types
Latest filing 2025-02-07 Regulatory Filings
Country IN India
Listing BSE.NS ORTINGLOBE

About ORTIN GLOBAL LIMITED

https://www.ortinlabsindia.com/

Ortin Global Limited is a pharmaceutical enterprise engaged in the development, manufacture, and marketing of active pharmaceutical ingredients (APIs), intermediates, and finished dosage formulations. The company maintains a diverse product portfolio covering various therapeutic segments, such as anti-diabetics, anti-hypertensives, anti-retrovirals, analgesics, and anti-pyretics. Its operations include the synthesis of complex chemical molecules and the production of oral solids and liquids, including tablets, capsules, and syrups. With a focus on integrated manufacturing processes, the company serves both domestic and international healthcare markets. Ortin Global Limited prioritizes research and development to expand its product offerings and optimize production techniques, ensuring compliance with established quality standards across its manufacturing facilities.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-02-07 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notice from Ortin Global Limited to stock exchanges about an upcoming Board Meeting scheduled for 12-02-2025. The purpose of the meeting includes consideration of unaudited financial results for the quarter ended 31-12-2024 and a limited review report. The document also mentions the closure of the trading window for insiders until 48 hours after the results declaration. The document is short (2187 characters) and serves as an intimation or announcement of a future event (board meeting and financial results release), not the financial results report itself. It does not contain actual financial data or detailed analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-02-07 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a compliance certificate issued under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018, for the quarter ended 31-12-2024. It is addressed to stock exchanges and includes a certificate from the company's Registrar and Transfer Agent (RTA) confirming the details of securities dematerialized/rematerialized during the period. The document length is 2316 characters, which is relatively short and primarily serves as a regulatory compliance certificate rather than a full financial report or announcement. It does not contain financial statements, management discussion, or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-11 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notice from Ortin Global Limited addressed to stock exchanges BSE and NSE. It announces the closure of the trading window under SEBI (Prohibition of Insider Trading) Regulations, 2015, specifying the period of closure from January 1, 2025, until 48 hours after the declaration of the company's un-audited financial results for the quarter ended December 31, 2024. It also mentions that the date of the Board Meeting to consider these results will be intimated later. The document is short (1999 characters) and serves as an announcement related to insider trading compliance and upcoming financial results, but it does not contain any financial data or the results themselves. It is not a report but a regulatory announcement related to trading restrictions and compliance. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-27 English
Copy of Newspaper Publication
Regulatory Filings
2024-11-19 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) dated 15.11.2024, referencing the publication of un-audited financial results for the quarter and half year ended 30.09.2024. It mentions compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and encloses newspaper clippings of the financial results. The document is about the publication of quarterly un-audited financial results, which corresponds to an Interim / Quarterly Report. The document length is 15,000 characters, indicating it likely contains substantive financial data rather than just an announcement. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2025
2024-11-15 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.